Quarterly report pursuant to Section 13 or 15(d)

Inventory (Tables)

v3.21.2
Inventory (Tables)
9 Months Ended
Sep. 30, 2021
Inventory Disclosure [Abstract]  
Schedule of inventories
Inventory is comprised of unprocessed tissue, work-in-process, Avance® Nerve Graft, Axoguard® Nerve Connector, Axoguard® Nerve Protector, Axoguard® Nerve Cap, Acroval® Neurosensory and Motor Testing System, Axotouch® Two-Point Discriminator and supplies. Inventory is valued at the lower of cost (first-in, first-out) or net realizable value and consists of the following:
(In thousands) September 30,
2021
December 31,
2020
Finished goods $ 10,687  $ 8,876 
Work in process 580  751 
Raw materials 4,186  2,902 
Inventory $ 15,453  $ 12,529